194 related articles for article (PubMed ID: 7790077)
1. Rats clearing a vaginal infection by Candida albicans acquire specific, antibody-mediated resistance to vaginal reinfection.
Cassone A; Boccanera M; Adriani D; Santoni G; De Bernardis F
Infect Immun; 1995 Jul; 63(7):2619-24. PubMed ID: 7790077
[TBL] [Abstract][Full Text] [Related]
2. Protective role of antimannan and anti-aspartyl proteinase antibodies in an experimental model of Candida albicans vaginitis in rats.
De Bernardis F; Boccanera M; Adriani D; Spreghini E; Santoni G; Cassone A
Infect Immun; 1997 Aug; 65(8):3399-405. PubMed ID: 9234804
[TBL] [Abstract][Full Text] [Related]
3. A highly immunogenic recombinant and truncated protein of the secreted aspartic proteases family (rSap2t) of Candida albicans as a mucosal anticandidal vaccine.
Sandini S; La Valle R; Deaglio S; Malavasi F; Cassone A; De Bernardis F
FEMS Immunol Med Microbiol; 2011 Jul; 62(2):215-24. PubMed ID: 21535228
[TBL] [Abstract][Full Text] [Related]
4. Intravaginal and intranasal immunizations are equally effective in inducing vaginal antibodies and conferring protection against vaginal candidiasis.
De Bernardis F; Boccanera M; Adriani D; Girolamo A; Cassone A
Infect Immun; 2002 May; 70(5):2725-9. PubMed ID: 11953420
[TBL] [Abstract][Full Text] [Related]
5. Local anticandidal immune responses in a rat model of vaginal infection by and protection against Candida albicans.
de Bernardis F; Santoni G; Boccanera M; Spreghini E; Adriani D; Morelli L; Cassone A
Infect Immun; 2000 Jun; 68(6):3297-304. PubMed ID: 10816477
[TBL] [Abstract][Full Text] [Related]
6. Candida-specific antibodies during experimental vaginal candidiasis in mice.
Wozniak KL; Wormley FL; Fidel PL
Infect Immun; 2002 Oct; 70(10):5790-9. PubMed ID: 12228309
[TBL] [Abstract][Full Text] [Related]
7. Systemic and mucosal immunization with Candida albicans hsp90 elicits hsp90-specific humoral response in vaginal mucosa which is further enhanced during experimental vaginal candidiasis.
Raska M; Belakova J; Horynova M; Krupka M; Novotny J; Sebestova M; Weigl E
Med Mycol; 2008 Aug; 46(5):411-20. PubMed ID: 18608941
[TBL] [Abstract][Full Text] [Related]
8. [IgA, IgE and IgG subclasses to Candida albicans in serum and vaginal fluid from patients with vulvovaginal candidiasis].
de Carvalho RJ; Cunha CM; Silva DA; Sopelete MC; Urzedo JE; Moreira TA; Moraes Pde S; Taketomi EA
Rev Assoc Med Bras (1992); 2003; 49(4):434-8. PubMed ID: 14963598
[TBL] [Abstract][Full Text] [Related]
9. A vaccine and monoclonal antibodies that enhance mouse resistance to Candida albicans vaginal infection.
Han Y; Morrison RP; Cutler JE
Infect Immun; 1998 Dec; 66(12):5771-6. PubMed ID: 9826353
[TBL] [Abstract][Full Text] [Related]
10. Vaginal eosinophils and IgE antibodies to Candida albicans in women with recurrent vaginitis.
Witkin SS; Jeremias J; Ledger WJ
J Med Vet Mycol; 1989; 27(1):57-8. PubMed ID: 2666634
[TBL] [Abstract][Full Text] [Related]
11. Candida albicans mannan extract-protein conjugates induce a protective immune response against experimental candidiasis.
Han Y; Ulrich MA; Cutler JE
J Infect Dis; 1999 Jun; 179(6):1477-84. PubMed ID: 10228070
[TBL] [Abstract][Full Text] [Related]
12. Partial protection against experimental vaginal candidiasis after mucosal vaccination with heat-killed Candida albicans and the mucosal adjuvant LT(R192G).
Cárdenas-Freytag L; Steele C; Wormley FL; Cheng E; Clements JD; Fidel PL
Med Mycol; 2002 Jun; 40(3):291-9. PubMed ID: 12146759
[TBL] [Abstract][Full Text] [Related]
13. Mice immunized by primary vaginal Candida albicans infection develop acquired vaginal mucosal immunity.
Fidel PL; Lynch ME; Conaway DH; Tait L; Sobel JD
Infect Immun; 1995 Feb; 63(2):547-53. PubMed ID: 7822020
[TBL] [Abstract][Full Text] [Related]
14. An outline of the role of anti-Candida antibodies within the context of passive immunization and protection from candidiasis.
Cassone A; De Bernardis F; Torososantucci A
Curr Mol Med; 2005 Jun; 5(4):377-82. PubMed ID: 15977993
[TBL] [Abstract][Full Text] [Related]
15. Candida vaginitis: virulence, host response and vaccine prospects.
De Bernardis F; Graziani S; Tirelli F; Antonopoulou S
Med Mycol; 2018 Apr; 56(suppl_1):26-31. PubMed ID: 29538739
[TBL] [Abstract][Full Text] [Related]
16. A virosomal vaccine against candidal vaginitis: immunogenicity, efficacy and safety profile in animal models.
De Bernardis F; Amacker M; Arancia S; Sandini S; Gremion C; Zurbriggen R; Moser C; Cassone A
Vaccine; 2012 Jun; 30(30):4490-8. PubMed ID: 22561143
[TBL] [Abstract][Full Text] [Related]
17. Human domain antibodies against virulence traits of Candida albicans inhibit fungus adherence to vaginal epithelium and protect against experimental vaginal candidiasis.
De Bernardis F; Liu H; O'Mahony R; La Valle R; Bartollino S; Sandini S; Grant S; Brewis N; Tomlinson I; Basset RC; Holton J; Roitt IM; Cassone A
J Infect Dis; 2007 Jan; 195(1):149-57. PubMed ID: 17152019
[TBL] [Abstract][Full Text] [Related]
18. Interplay between protective and inhibitory antibodies dictates the outcome of experimentally disseminated Candidiasis in recipients of a Candida albicans vaccine.
Bromuro C; Torosantucci A; Chiani P; Conti S; Polonelli L; Cassone A
Infect Immun; 2002 Oct; 70(10):5462-70. PubMed ID: 12228271
[TBL] [Abstract][Full Text] [Related]
19. Protection against rat vaginal candidiasis by adoptive transfer of vaginal B lymphocytes.
De Bernardis F; Santoni G; Boccanera M; Lucciarini R; Arancia S; Sandini S; Amantini C; Cassone A
FEMS Yeast Res; 2010 Jun; 10(4):432-40. PubMed ID: 20402794
[TBL] [Abstract][Full Text] [Related]
20. Comparison of two Candida mannan vaccines: the role of complement in protection against disseminated candidiasis.
Han Y; Rhew KY
Arch Pharm Res; 2012 Nov; 35(11):2021-7. PubMed ID: 23212645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
